U.S. SUPREME COURT RULES AGAINST AMGEN'S BID TO REVIVE PATENTS ON ITS CHOLESTEROL DRUG REPATHA
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
314.7 USD | -0.65% | +0.59% | +9.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.27% | 171B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+0.45% | 163B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- U.s. Supreme Court Rules Against Amgen's Bid To Revive Patents O…